Mufg Securities Americas Inc. Biogen Inc. Transaction History
Mufg Securities Americas Inc.
- $861 Billion
- Q1 2025
A detailed history of Mufg Securities Americas Inc. transactions in Biogen Inc. stock. As of the latest transaction made, Mufg Securities Americas Inc. holds 2,591 shares of BIIB stock, worth $330,430. This represents 0.04% of its overall portfolio holdings.
Number of Shares
2,591
Previous 2,151
20.46%
Holding current value
$330,430
Previous $329 Million
7.79%
% of portfolio
0.04%
Previous 0.04%
Shares
2 transactions
Others Institutions Holding BIIB
# of Institutions
1,025Shares Held
127MCall Options Held
2.29MPut Options Held
4.26M-
Vanguard Group Inc Valley Forge, PA17MShares$2.17 Billion0.04% of portfolio
-
Primecap Management CO Pasadena, CA15.9MShares$2.03 Billion1.84% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$1.85 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.4MShares$943 Million0.04% of portfolio
-
Wellington Management Group LLP Boston, MA4.67MShares$596 Million0.13% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $18.4B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...